正海生物：持续巩固种植领域优势地位

证券之星05-26

证券之星消息，正海生物(300653)05月25日在投资者关系平台上答复投资者关心的问题。

投资者提问：公司称口腔修复产品通过经销+电商，那么进来在各大牙科电商平台上修复膜销售量统计被瑞盛反超且被兰度大幅追上甚至平行，公司对此有何感想和后续计划？

正海生物回复：尊敬的投资者您好，感谢您对公司的关注！面对民营口腔修复膜市场的挑战，公司持续巩固相关产品在种植领域的优势地位，坚定执行精准化营销策略，不断增进与头部终端的紧密合作，稳定渠道对市场份额的覆盖。同时，公司将加快新品上市与推广，协同发挥膜粉产品组合能力，进一步提升市场竞争能力。再次感谢您的关注与支持！

以上内容为证券之星据公开信息整理，不构成投资建议。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2638569542?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-05-26 09:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2638569542","market":"fut","top_or_hot":-1,"title":"正海生物：持续巩固种植领域优势地位","media":"证券之星","content":"<html><body><p>证券之星消息，<a href=\"https://laohu8.com/S/300653\">正海生物</a>(300653)05月25日在投资者关系平台上答复投资者关心的问题。</p><p>投资者提问：公司称口腔修复产品通过经销+电商，那么进来在各大牙科电商平台上修复膜销售量统计被瑞盛反超且被兰度大幅追上甚至平行，公司对此有何感想和后续计划？</p><p>正海生物回复：尊敬的投资者您好，感谢您对公司的关注！面对民营口腔修复膜市场的挑战，公司持续巩固相关产品在种植领域的优势地位，坚定执行精准化营销策略，不断增进与头部终端的紧密合作，稳定渠道对市场份额的覆盖。同时，公司将加快新品上市与推广，协同发挥膜粉产品组合能力，进一步提升市场竞争能力。再次感谢您的关注与支持！</p><p>以上内容为证券之星据公开信息整理，不构成投资建议。</p></body></html>","source":"stockstar","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>正海生物：持续巩固种植领域优势地位</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n正海生物：持续巩固种植领域优势地位\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-05-26 09:09 北京时间&nbsp;&nbsp;&nbsp;<a href=https://stock.stockstar.com/RB2026052600006553.shtml><strong>证券之星</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>证券之星消息，正海生物(300653)05月25日在投资者关系平台上答复投资者关心的问题。投资者提问：公司称口腔修复产品通过经销+电商，那么进来在各大牙科电商平台上修复膜销售量统计被瑞盛反超且被兰度大幅追上甚至平行，公司对此有何感想和后续计划？正海生物回复：尊敬的投资者您好，感谢您对公司的关注！面对民营口腔修复膜市场的挑战，公司持续巩固相关产品在种植领域的优势地位，坚定执行精准化营销策略，不断增进...</p>\n\n<a href=\"https://stock.stockstar.com/RB2026052600006553.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"300653","symbol_name":"正海生物","start_time":0,"source_url":"https://stock.stockstar.com/RB2026052600006553.shtml","article_id":"2638569542","we_media_id":"1082532455","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2638569542","pubTimestamp":1779757749,"columns":[],"sourceInfo":{"source_id":"stockstar","name":"证券之星"},"weMediaInfo":{"media_name":"证券之星","introduction":"证券之星始创于1996年，是国内领先的金融信息及综合服务平台。关注证券之星，即时获取有价值的财经资讯。","home_visible":1,"id":"1082532455","head_image":"https://community-static.tradeup.com/news/2e305640fc27210243042d09d3a7fa3f"},"summary":"证券之星消息，正海生物05月25日在投资者关系平台上答复投资者关心的问题。面对民营口腔修复膜市场的挑战，公司持续巩固相关产品在种植领域的优势地位，坚定执行精准化营销策略，不断增进与头部终端的紧密合作，稳定渠道对市场份额的覆盖。以上内容为证券之星据公开信息整理，不构成投资建议。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"300653":"正海生物","BK0046":"生物疫苗","BK0251":"专用设备"},"translate_title":"Zhenghai Bio: Continue to consolidate its dominant position in the planting field","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300653":1.5},"content_text":"证券之星消息，正海生物(300653)05月25日在投资者关系平台上答复投资者关心的问题。投资者提问：公司称口腔修复产品通过经销+电商，那么进来在各大牙科电商平台上修复膜销售量统计被瑞盛反超且被兰度大幅追上甚至平行，公司对此有何感想和后续计划？正海生物回复：尊敬的投资者您好，感谢您对公司的关注！面对民营口腔修复膜市场的挑战，公司持续巩固相关产品在种植领域的优势地位，坚定执行精准化营销策略，不断增进与头部终端的紧密合作，稳定渠道对市场份额的覆盖。同时，公司将加快新品上市与推广，协同发挥膜粉产品组合能力，进一步提升市场竞争能力。再次感谢您的关注与支持！以上内容为证券之星据公开信息整理，不构成投资建议。","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2638569542","isCrawlerRequest":true}